M&A bids stoke biotech stocks
March 01, 2010 at 10:54 AM EST
Biotech stocks trade higher, lifted by German conglomerate Merck KGaA’s plans to buy research toolmaker Millipore for $7.5 billion and by Japanese drugmaker Astellas Pharma’s move to launch a hostile $3.5 billion bid to acquire OSI Pharmaceuticals.
